[HTML][HTML] Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
H Scharnagl, T Stojakovic, B Dieplinger, H Dieplinger… - Atherosclerosis, 2019 - Elsevier
Background and aims Lipoprotein (a)[Lp (a)] is an established causal risk factor for
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays.
H Scharnagl, T Stojakovic, B Dieplinger… - …, 2019 - europepmc.org
Methods We measured Lp (a) serum concentrations using six different assays, providing Lp
(a) in mg/dl (Denka Seiken, Abbott Quantia, Beckman, Diasys 21FS, and Siemens N Latex) …
(a) in mg/dl (Denka Seiken, Abbott Quantia, Beckman, Diasys 21FS, and Siemens N Latex) …
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
H Scharnagl, T Stojakovic, B Dieplinger… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background and aims Lipoprotein (a)[Lp (a)] is an established causal risk factor for
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
[引用][C] Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
H Scharnagl, T Stojakovic, B Dieplinger, H Dieplinger… - Atherosclerosis, 2019 - cir.nii.ac.jp
Comparison of lipoprotein (a) serum concentrations measured by six commercially available
immunoassays | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
immunoassays | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
H Scharnagl, T Stojakovic, B Dieplinger, H Dieplinger… - 2019 - katalog.ub.uni-heidelberg.de
Background and aims-Lipoprotein (a)[Lp (a)] is an established causal risk factor for
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
H Scharnagl, T Stojakovic, B Dieplinger… - …, 2019 - atherosclerosis-journal.com
Background and aims Lipoprotein (a)[Lp (a)] is an established causal risk factor for
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
H Scharnagl, T Stojakovic, B Dieplinger, H Dieplinger… - 2019 - katalog.ub.uni-heidelberg.de
Background and aims-Lipoprotein (a)[Lp (a)] is an established causal risk factor for
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …
cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other …